OXALIPLATIN AG oxaliplatin 50 mg/10 mL concentrated injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Download Laporan Penilaian Awam (PAR)
29-11-2017

Bahan aktif:

oxaliplatin, Quantity: 50 mg

Boleh didapati daripada:

Alphapharm Pty Ltd

INN (Nama Antarabangsa):

Oxaliplatin

Borang farmaseutikal:

Injection, concentrated

Komposisi:

Excipient Ingredients: water for injections

Laluan pentadbiran:

Intravenous

Unit dalam pakej:

Pack of 1 x vial

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Oxaliplatin is indicated for adjuvant treatment of stage III (Duke's C) colon cancer, in combination with a fluoropyrimidine agent,Oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,Oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,Oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

Ringkasan produk:

Visual Identification: Clear, colourless solution, practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2012-03-27